Tubers of Corydalis cava were extracted with ethanol and fractionated using n-hexane, chloroform and ethanol. Repeated column chromatography, preparative TLC and crystallization led to the isolation of fifteen isoquinoline alkaloids. The chemical structures of the isolated compounds were determined on the basis of spectroscopic techniques and by comparison with literature data. All isolated compounds were tested for human blood acetylcholinesterase (HuAChE) and human plasma butyrylcholinesterase (HuBuChE) inhibitory activity. (+)-Canadaline inhibited acetylcholinesterase as well as butyrylcholinesterase in a dose-dependent manner with IC 50 values of 20.1 ± 1.1 µM and 85.2 ± 3.2 µM, respectively. (+)-Canadine, with an IC 50 value of 12.4 ± 0.9 µM, was the most potent inhibitor of acetylcholinesterase, whilst (±)-corycavidine and (+)-bulbocapnine were effective inhibitors of butyrylcholinesterase with IC 50 values of 46.2 ± 2.4 µM and 67.0 ± 2.1 µM, respectively. The other isolated alkaloids were considered inactive (IC 50 > 100 µM).
Neurodegenerative diseases are a group of conditions that result from either chronic breakdown and progressive functional or structural loss of neurons, particularly of the central nervous system (CNS). Alzheimer´s disease (AD) is the most predominant cause of dementia in the elderly, affecting 25% of the population over 80 years of age [1a] . In patients with AD, brain regions associated with higher mental functions (neocortex and hippocampus) are affected by extracellular deposits of β-amyloid plaques [1b] and intracellular deposits of neurofibrillary tangles [1c] . There is also a progressive lost of neurons in the basal forebrain [1d] , which is the major source of cholinergic innervations of the neocortex and hippocampus. Deficit of cholinergic functions and decreased levels of the neurotransmitter acetylcholine (ACh) in the cortex is responsible for the memory impairments [1e] . The principal role of acetylcholinesterase (AChE) is the termination of nerve impulse transmission at the cholinergic synapses by rapid hydrolysis of acetylcholine (ACh). Moreover, in late AD stages, levels of AChE have declined by up to 85% and BuChE represents the predominant cholinesterase in the brain. BuChE, primarily associated with glial cells, but also with specific neuronal pathways, cleaves ACh in a manner similar to that of AChE to terminate its physiological action [1f] . Currently, cholinesterase inhibition is the most widely used therapeutic treatment for the symptoms of AD [1g-1i]. In the screening of natural inhibitors of acetylcholinesterase, alkaloid extracts from species of Fumariaceae have demonstrated AChE inhibitory activity [2a] . An overview of natural product inhibitors of AChE was reported by Hostettmann in 2006 [2b], and Mukherjee in 2007 [2c] .
Previous reports showed that several species of Corydalis have been used in the treatment of memory dysfunction in folk medicine [3a] . During the Middle Ages, the tubers of C. cava were used for headache, neuroses, tremor, pain and paralysis of extremities [3b]. The tubers of this plant are a very rich source of isoquinoline alkaloids of various structural types. So far, about forty alkaloids have been isolated and characterized [3b-3d], the main alkaloid being bulbocapnine. The last new compound isolated from C. cava was a secoberbine alkaloid R(-)-canadaline [3e]. Several alkaloids isolated from C. cava or from others Corydalis species were tested for their cholinesterase inhibitory activity. Bulbocapnine and corydaline, both isolated from C. cava, inhibited acetylcholinesterase in a dose-dependent manner with IC 50 values of 40 ± 2 μM and 15 ± 3 μM, respectively [3f]. From the tubers of C. turtschaninovii, 16 isoquinoline alkaloids were isolated and tested. The best activity was demonstrated by the quaternary protoberberines berberine, pseudocoptisine and pseudoberberine [3g] . It is known that the quaternary nitrogen plays an important role in binding with the enzyme [3h]; however, these compounds might have problems with crossing the blood-brain barrier [3i] . For this reason we concentrated our work on the isolation of tertiary alkaloids.
In the course of screening for natural cholinesterase inhibitors, we found that the alkaloid extract from C. cava showed promising cholinesterase activity. This communication deals with the isolation of isoquinoline alkaloids from tubers of C. cava and the inhibitory effect of these compounds on the activity of erythrocyte AChE (HuAChE) and plasma BuChE (HuBuChE) from human blood.
Column chromatography (CC) and preparative TLC led to the isolation of 15 compounds (1-15), all of which showed a positive reaction with Dragendorff´s reagent. Based on the mass, 1 H and 13 C NMR spectra, the isolated alkaloids could be divided into six structural types; aporphine, benzophenanthridine, morphinane, protoberberine, protopine and secoberbine. By comparing spectral data with those reported in the literature, the compounds were identified as (+)-canadine (1), (+)-corydaline (2), (-)corycavamine (3), (+)-tetrahydropalmatine (4), (+)corynoline (5), (±)-corycavidine (6), (+)-canadaline (7), allocryptopine (8) memory and cognitive deficits of the patients by diminishing the breakdown of acetylcholine at the synaptic site in the brain. As mentioned, in late AD stages, levels of AChE have declined by up to 85% and BuChE represents the predominant cholinesterase in the brain. Due to this, inhibition of BuChE is a new approach to intercede in the progression of AD, and the research of new inhibitors with dual enzymatic activity is very important.
The inhibitory activity of compounds 1-15 was studied in vitro using the colorimetric method of Ellman et al. [7] .
Red blood cells were used as a source of HuAChE and human plasma of HuBuChE. The results are expressed as IC 50 values, with galanthamine and huperzine A as positive controls (Table 1) . Against BuChE, huperzine A was inactive (IC 50 > 1 mM). The minor secoberbine alkaloid (+)-canadaline (7) significantly inhibited HuAChE as well as HuBuChE (IC 50,HuAChE = 20.1 ± 1.1 µM, IC 50,HuBuChE = 85.2 ± 3.2 µM). (+)-Canadine (1) was the most potent compound inhibiting HuAChE in a dose-dependent manner with an IC 50 value of 12.4 ± 0.9 μM. Better anti-HuBuChE activity than the standard galanthamine was demonstrated by both (±)-corycavidine (6) and (+)-bulbocapnine (10) (IC 50, HuBuChE = 46.2 ± 1.5 µM and IC 50, HuBuChE = 67.0 ± 1.8 µM). (±)-Corycavidine (6) present study (+)-corynoline (5) was inactive. The other isolated compounds from the tubers of C. cava were considered inactive against both HuAChE and HuBuChE.
In conclusion, the present study shows that some of the isolated alkaloids might be useful for the treatment of AD. However, more studies are needed before these compounds may be considered as useful therapeutic agents for the prevention of AD. 
Experimental

Extraction and isolation:
The dried tubers of C. cava (11.3 kg) were finely powdered and exhaustively extracted by percolation at room temperature with 95 % EtOH (1:9). The solvent was evaporated, the viscous brown residue (1.23 kg) treated with 2% HCl (6 L), filtered, the filtrate treated with 10% Na 2 CO 3 (pH ~ 9-10) and exhaustively extracted with CHCl 3 (6 × 1.5 L). The organic layer was evaporated to give 300 g of residue. For purification, this residue was dissolved in 2% HCl, treated with 10 % Na 2 CO 3 (pH ~ 9) and extracted with Et 2 O (6 × 2 L). The ether extract (200 g) was subjected to silica gel CC using step gradient elution with n-hexane: CHCl 3 (1:1, 2:3 and 1:9, each 3 L) and then continuing with CHCl 3 : EtOH (100: 1, 97:3, 95:5, 9:1, 85:15, 8:2, 75:25, 7:3, 65:35, 6 :4 and 1:1, 1.5 L each) to afford 7 fractions (A-G). Preparative TLC (c-hexane: Et 2 NH, 97:3, 3 times) of fraction A (150 mg) gave compounds 1 (10 mg) and 2 (30 mg). Fraction B (65 g) was further chromatographed on silica gel using step gradient elution with n-hexane: CHCl 3 (1:1, 2:3, 1:4, 1:9, each 3.5 L) to give 3 subfractions B/1-B/3. Compound 3 (2.55 g) was isolated from subfraction B/1 (4.3 g) by additional CC on silica gel using n-hexane: CHCl 3 (3:2) as the solvent system. Subfraction B/2 (38 g) was recrystallized from CHCl 3 : EtOH to give compound 4 (29.3 g). Subfraction B/3 (1.5 g) was subjected to preparative TLC (c-hexane: Et 2 NH, 95:5, 3 times) to give compounds 5 (136 mg) and 6 (55 mg). Fraction C (250 mg) and D (480 mg) gave, after crystallization from CHCl 3 : EtOH, compounds 7 (115 mg) and 8 (179 mg), respectively. Fraction E (3.5 g) was separated on a silica gel column using n-hexane: CHCl 3 (1:4) as mobile phase to give 2 subfractions E/1 (2.5 g) and E/2 (2.2 g). Both were subjected to preparative TLC (toluene: Et 2 NH, 95:5, 3 times) to give compounds 9 (1.4 g) and 10 (1.06 g). Fraction F (3.2 g) was further chromatographed by silica gel CC using step gradient elution with CHCl 3 : EtOH (9:1, 4:1 and 3:2, each 500 mL), followed by preparative TLC (toluene: Et 2 NH, 9:1, 3 times) to give successively 11 (85 mg) and 12 (451 mg). Fraction G (4.2 g) was separated on a silica gel column using elution with CHCl 3 : EtOH (4:1, 3:2, 1:1 and 1:4, each 500 mL) to give 3 subfractions G/1-G/3, all of which were subjected to preparative TLC (toluene: CHCl 3 : EtOH: Et 2 NH, 70:20:10:3, 2 times) to give compounds 13 (1.63 g), 14 (476 mg) and 15 (265 mg).
Preparation of red blood cells ghosts:
Ghosts were prepared from freshly drawn blood (taken from healthy volunteers), to which 1 mL sodium citrate per 10 mL blood was added, according to Steck and Kant [8] , with slight modification. Briefly, plasma (HuBuChE) was removed from the whole blood by centrifugation at 4000 rpm in a Boeco U-32R centrifuge fitted with a Hettich 1611 rotor. Red blood cells were transferred to 50 mL tubes and washed 3 times with 5 mM phosphate buffer (pH 7.4) containing 150 mM sodium chloride (12,000 rpm, Avanti J-30I, rotor JA-30.50). The washed erythrocytes were stirred with 5 mM phosphate buffer (pH 7.4) for 10 mins to ensure lysis. The lysed cells were centrifuged at 20,000 rpm for 10 mins and then the ghosts (HuAChE) were washed 3 times with phosphate buffer.
Acetylcholinesterase and butyrylcholinesterase assay:
HuAChE and HuBuChE activities were determined using a modified method of Ellman et al. [7] with acetylthiocholine and butyrylthiocholine as substrates, respectively. Briefly, 25-50 μL of either ghosts or plasma, 650 μL of DTNB and 25 μL of either the sample or appropriate solvent as a blank sample, were added to the semi-micro cuvette. The reaction was initiated by addition of substrate (ATChI or BuTChI). The final proportion of DTNB and substrate was 1:1. The increase of absorbance at 436 nm (∆A) was measured for 1 min using a spectrophotometer (Shimadzu UV-1611). Each measurement was repeated 3 times. The % inhibition was calculated according to the formula: %I = 100-(∆A BL /∆A SA )*100, where ∆A BL is the increase of absorbance of the blank sample and ∆A SA is the increase of absorbance of the measured sample.
